1 month
+1.1%
price return
Year to date
+9.8%
price return
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
50 articles, 7 days
Analysts
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsWhat it reported, what was expected, and what comes next.
Reported Aug 5, 2026
Earnings per share
$6.01 expected
GAAP EPS was $7.94 and adjusted EPS was $8.38. The analyst basis could not be confirmed, so no beat or miss is shown.
FY2026 guidance
$85.00B to $87.00B
No comparable estimate
Next report
EPS expected
$8.95 to $11.30
Revenue expected
14 analysts
Last 30 days
Split both ways
Estimate drift
Change in 30 days
From the release
The three statements, quarter by quarter.
Sep 2025 to Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $17.60B | $19.29B | $19.80B | $22.97B |
| Cost of what it soldCost of revenue | $3.01B | $2.88B | $3.58B | $3.27B |
| Gross profit | $14.59B | $16.41B | $16.22B | $19.71B |
| What it spent | ||||
| Research and development | $3.47B | $3.80B | $3.51B | $3.82B |
| Sales and adminSelling, general and administrative | $2.74B | $3.34B | $2.93B | $3.43B |
| Other operating costsOperating costs not itemised in the filing's summary | — | $487.5M | $928.0M | $3.48B |
| Total operating expenses | $6.21B | $7.63B | $7.37B | $10.73B |
| What was left | ||||
| Operating profitOperating income | $8.39B | $8.78B | $8.85B | $8.98B |
| Interest on debtInterest expense | $179.6M | $123.0M | $332.0M | $345.0M |
| Profit before tax | $7.23B | $8.27B | $8.85B | $9.25B |
| TaxIncome tax expense | $1.65B | $1.63B | $1.45B | $2.15B |
| Net profitNet income | $5.58B | $6.64B | $7.40B | $7.09B |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $7.88B | $8.39B | $9.69B | $9.25B |
Business quality, value, and expectations at a glance.
Fundamentals
Reasonably priced and profitable.
Valuation
Quality
Growth
Filed positions and reported activity tied to this stock.
8 funds hold a position, insiders have been net selling, and 1 market voice is discussing it.
Real smart money
Insiders
Politicians
Trend, range, and the price levels that matter.
Technicals
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
$1180.1620D support
20D resistance
Returns
Price vs moving averages
Volume pace
Recent coverage and its overall tone.
News
Coverage is bullish
24 bullish · 25 neutral · 1 bearish
Tone of tracked coverage
Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement
Leans bullishAug 10Veru Q3 2026 Earnings Call Transcript
Leans bullishAug 10Bristol Myers to build $2.3 billion manufacturing site in Houston
Leans bullishAug 10Earnings call transcript: Veru posts Q3 2026 EPS beat as PLATEAU trial advances
BullishAug 10M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
BullishAug 10Lilly's weight-loss pill gets UK regulator's nod
BullishAug 10BofA raises MiniMed Group stock price target to $24 on exchange timing
Leans bullishAug 10NewEdge Advisors LLC Grows Stake in CVS Health Corporation $CVS
Leans bullishAug 10Michael Rulli
$1K to $15K · traded Dec 2
$1K
sold
Top traders
Trader D7ELong
entry $1212.81 · -$1K unrealized
$51K
position
Trader 232Short
entry $1025.57 · -$6K unrealized
$45K
position
Trader 2EEShort
entry $886.35 · -$8K unrealized
$34K
position
Trader 125Long
entry $1200.78 · -$573 unrealized
$30K
position
Trader 447Short
entry $922.01 · -$4K unrealized
$17K
position
AlphaYou
